Corporate News 27-May-22
Board of Astrazeneca Pharma India recommends Final Dividend
Of Rs.8 per share
Astrazeneca Pharma India announced that the Board of Directors of the Company at its meeting held on 26 May 2022, has recommended a Final dividend of Rs.8 per share (i.e.400%), subject to the approval of the shareholders.
Previous News
Astrazeneca Pharma India Ltd leads gainers in 'A' group
( Hot Pursuit - 24-Sep-24 12:00 )
Volumes spurt at Astrazeneca Pharma India Ltd counter
( Hot Pursuit - 24-Sep-24 14:30 )
Astrazeneca Pharma India to announce Quarterly Result
( Corporate News - 01-Nov-22 10:34 )
Astrazeneca Pharma India receives DCGI approval to import, market Selumetinib capsules
( Hot Pursuit - 27-Sep-21 09:37 )
Astrazeneca Pharma India reports standalone net loss of Rs 10.35 crore in the December 2017 quarter
( Results - Announcements 06-Feb-18 17:19 )
Volumes spurt at Elgi Equipments Ltd counter
( Hot Pursuit - 05-Jul-22 14:30 )
AstraZeneca Pharma India appoints director
( Corporate News - 13-Aug-20 10:21 )
Volumes spurt at AIA Engineering Ltd counter
( Hot Pursuit - 12-Nov-20 11:00 )
Astrazeneca Pharma India appoints director
( Corporate News - 08-Aug-19 20:09 )
Astrazeneca Pharma gets nod from CDSCO to import Olaparib film coated tablets
( Hot Pursuit - 22-Nov-23 11:07 )
Astrazeneca Pharma India to announce Quarterly Result
( Corporate News - 24-Jan-19 17:22 )
Other Stories
ITD Cementation India wins order of Rs 1,937 cr
03-Oct-24 10:35
NIIT Learning Systems allots 1,666 equity shares under ESOP
03-Oct-24 10:30
Ashoka Metcast to discuss results
03-Oct-24 10:29
Emerald Finance to declare Quarterly Result
03-Oct-24 10:29
Rhetan TMT schedules board meeting
03-Oct-24 10:29
Shrenik to table results
03-Oct-24 10:29
Universal Arts to declare Quarterly Result
03-Oct-24 10:28
Three M Paper Boards to conduct board meeting
03-Oct-24 10:28
Arkade Developers to declare Quarterly Result
03-Oct-24 10:28
Worth Investment & Trading Company announces board meeting date
03-Oct-24 10:28
Back
Top
